The Cell & Gene Meeting is organized by the Alliance for Regenerative Medicine. This year featuring more than 90 company presentations by leading public and private companies, highlighting technical and clinical achievements…
The shareholders in Amniotics AB (publ), org. No. 559024-6558 (“Amniotics”), is hereby called to the Annual General Meeting on Thursday, April 15, 2021…
On the 27th of October 2020, Amniotics was approved to carry out activities as a Tissue Establishment by the Swedish Medical Products Agency. The authorization refers to the handling of human tissues and cells intended for the manufacture of medicinal products...
The Bridge & Medicon Village arranged a #iställetföralmedalen digital event on work & health. https://altitudemeetings.se/jobb-halsa/ Amniotics CEO Kåre Engilde participated in discussions on Swedish virus research. https://vimeo.com/431809235
Amniotics chairman Christer Fåhraeus was recently featured in Dagens Industri. The 25 million SEK that Amniotics now takes in venture capital will be enough to investigate the possibility of using the technology against Covid-19."We intended to use stem cells for a...
https://www.mediconvillage.se/sv/amniotics-featured-tv4-their-novel-source-mscs-treat-covid-19 Amniotics was recently featured in Swedish TV4, in regard to development of our cell-therapeutic for COVID-19 diseases. Studies have shown that mesenchymal stem cells can...